| Talks： |
Cardiometabolic Phenotyping in OSA: Who Benefits Most from Treatment
阻塞型睡眠呼吸中止症的心臟代謝風險：哪些患者最能從治療中獲益？ |
| Name： |
| 陳永瑄（Yung-Hsuan Chen） |
| Position： |
| Attending Physician |
| Affiliation： |
Division of Pulmonary Medicine, Department of Internal Medicine, National Taiwan University Hospital;
Internal Medicine, College of Medicine, National Taiwan University
|
| Email： |
|
| Photo： |
 |
| Research Interests： |
1. Cardiovascular and metabolic consequences of obstructive sleep apnea
2. Clinical phenotyping and personalized treatment of obstructive sleep apnea
|
| Selected Publications： |
| 1. Chen, L. Y., Chen, Y. H.*, Hu, S. W., Lin, M. T., Lee, P. L., Chiang, A. A., & Tu, Y. K. (2022). In search of a better CPAP interface: A network meta-analysis comparing nasal masks, nasal pillows and oronasal masks. Journal of Sleep Research, 31(6), e13686. https://doi.org/10.1111/jsr.13686 |
| Abstract： |
| Obstructive sleep apnea (OSA) is a heterogeneous disorder, and the apnea-hypopnea index alone does not adequately capture individual cardiometabolic risk. Emerging evidence suggests that nocturnal hypoxemia, sleep characteristics, symptom profiles, metabolic dysfunction, and inflammation may identify clinically meaningful OSA phenotypes with different cardiovascular risks and treatment responses. This presentation will review current approaches to cardiometabolic phenotyping in OSA and explore how these characteristics may help identify patients most likely to benefit from treatment. Moving beyond an AHI-centered approach may enable more precise risk stratification and support personalized treatment strategies aimed at improving cardiovascular and metabolic outcomes. |
| 2026年會： |
|
|